Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 19, 2022
LSPediA Inc., a cloud solutions provider for the pharmaceutical industry, added Patrick O'Donohue to its Leadership Team as Vice President of Operations.
read more
LSPedia announced the appointment of Erin Parsons as Director of Compliance.
read more
Thursday, February 27, 2025
LSPedia has secured its second major U.S. government contract, the MMCAP Infuse DSCSA Compliance contract. This follows its national DSCSA contract with the U.S. Department of Veterans Affairs, further solidifying LSPedia's leadership position in the...
read more
Wednesday, August 14, 2024
LSPedia, a provider of global product traceability, announced a strategic partnership with Pharma Logistics, a provider of pharmaceutical reverse distribution. This collaboration aims to transform the pharmaceutical supply chain by offering turnkey ...
read more
LSNE has announced the AEMPS has approved the manufacturing of clinical stage biotechnology based therapeutic products at its aseptic fill finish facility in León, Spain.
read more
Tuesday, January 21, 2020
LSNE announced a successful Pre-Approval Inspection performed by the FDA at its aseptic fill finish facility in León, Spain.
read more
Lyophilization Services of New England, Inc. (LSNE) has announced the successful completion of two FDA inspections of their aseptic manufacturing facilities. These inspections were conducted in January and February of 2017.
read more
Wednesday, October 02, 2019
LSNE announces approval of an ANDA from the FDA, for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain.
read more
Thursday, February 06, 2020
LSNE Contract Manufacturing broke ground on a 26,000 square foot addition of its existing 7 Commerce facility on the Bedford, New Hampshire campus.
read more
Wednesday, January 20, 2021
LSNE Contract Manufacturing expands vial filling and lyophilization capacity with the addition of a new automated aseptic fill line.
read more
Tuesday, October 12, 2021
LSNE Contract Manufacturing, a leading global contract development and manufacturing organization (CDMO), today announces it has doubled its sterile drug product lyophilization capacity at its Madison, Wisconsin parenteral manufacturing facility, ...
read more
LSNE Contract Manufacturing announced they have signed a manufacturing supply agreement with Selecta Biosciences.
read more
Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain.
read more
LSNE has received GMP certification from Brazil's National Health Surveillance Agency - ANVISA following an inspection and audit of its manufacturing facility in Manchester, NH in February.
read more
LSNE announced a strategic plan to expand its QC laboratory in Bedford and provide new employment opportunities for its analytical and operations workforce.
read more